Merck
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Merck
Jun 21, 2024, 11:57 |
Blog
Elad Sharon: Two of my major trials led to FDA Oncology approvals
Elad Sharon, Clinical and Translational Director of Dana-Farber Cancer Institute, shared on X/Twitter: "Past week,…
Jun 11, 2024, 14:31 |
Insight
Sofia Tzamarelou: Georgi Ivanov wrote a fantastic piece on ASCO 2024
Sofia Tzamarelou, Senior Consultant at Commetric, shared on LinkedIn: “Our very own Georgi Ivanov wrote…
Jun 8, 2024, 17:22 |
Blog
Roger Li: Final results of CORE001 trial at Nature Medicine
Roger Li, Urologic oncologist at Moffitt Cancer Center, shared on X/Twitter: "Final results of CORE001 trial…
Jun 8, 2024, 11:24 |
Blog
Kristiyana Kaneva: Packed several days at ASCO with Tempus AI
Kristiyana Kaneva, Executive Medical Director, Clinical Development at Tempus AI, shared a post on LinkedIn:…
Jun 5, 2024, 10:01 |
Insight
Gergely Szótér: The future of cancer treatment is here
Gergely Szótér, Strategic Partner Business Analyst at Avantor, recently shared a post on X: "The…
Jun 1, 2024, 17:29 |
Blog
Harold Cottin: Very pleased to moderate with Pauline L'Hénaff this WHA77 side-event on multi-sectorial partnerships for Health equity hosted by City Cancer Challenge
Harold Cottin, Visiting lecturer – Global Health at Sciences Po, shared on LinkedIn: "I was very pleased…
May 20, 2024, 11:06 |
Blog
Eslam Hamdy: We successfully executed two sessions of Merck Saudi Fertility ART Forum in both Riyadh and Jeddah
Eslam Hamdy, Franchise Manager at Merck, Saudi Arabia shared a post on LinkedIn: “Did you…
May 1, 2024, 11:15 |
Blog
Sachin H. Jain: People who lead with personal integrity stand apart
Sachin H. Jain, President and CEO, SCAN Group and Health Plan, shared a post on LinkedIn:…
Apr 20, 2024, 06:35 |
Career
Sara Vergara: I’m happy to share that I’ve been promoted to Director of US Medical Affairs - Hematology (Myeloid) at Bristol Myers Squibb
Sara Vergara shared on LinkedIn: "I’m happy to share that I’ve been promoted to Director…
Apr 20, 2024, 06:03 |
Insight
Toni Choueiri: The long-awaited OS results from KEYNOTE-564 are out at the New England Journal of Medicine!
Toni Choueiri shared on X/Twitter: "The long-awaited OS results from KEYNOTE-564 are out at the New…
1
2
3
All:
23
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube